l 2018
WO
13421. KEFIRAN FOR USE IN REGENERATIVE MEDICINE AND/OR TISSUE ENGINEERING
Abstract
The present disclosure relates to an exopolysaccharide, in particular to Kefiran and its use in regenerative medicine and/or tissue engineering, compositions, scaffolds and the use...